Back to search results

TEAM Me Exercise Program for Young Cancer Patients Undergoing Stem Cell Transplant

This study, called "TEAM Me," is looking at how an exercise program can help children and young adults (ages 6-29) with cancer who are having a blood stem cell transplant. The program uses a "token economy" system, where participants earn stickers for walking and other activities, which they can then trade for rewards. Researchers want to see if this program can improve physical fitness, activity levels, quality of life, and overall function. The study will measure success by seeing how many patients complete the exercise program and if there are any side effects. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 60 participants. It is not specified if it's randomized or blinded.
What's involved
You would complete a 6-minute walk test and a timed get up and go test multiple times, and fill out surveys about your quality of life and fatigue. You would also participate in walking and other activities.
Compensation
Not stated in the trial record.
Follow-up
Your progress will be measured up to 100 days after your stem cell transplant.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04678427

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Recruiting
NAAges 6–29InterventionalSupportive care
M.D. Anderson Cancer Center
~60 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:6 Minute Walk Functional TestBehavioral InterventionSurvey AdministrationTimed Get Up and Go Test

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients who enroll and complete the serial measures
Measured over Up to 21 days post-hematopoietic stem cell transplant (HSCT)
+1 more outcome measured

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Explore related trials

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Where it's being run

2 sites across 1 states
Texas2

Study leadership

  • Priti Tewari · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Priti Tewari
[email protected]
713-792-6620
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be admitted to an inpatient pediatric ward for the purpose of HSCT for the treatment of malignancy
Be greater than or equal to 6 years of age and less than 30 years of age
Participants or guardians are willing and able to give written informed consent either prior to admission or within 48 hours following admission and to comply with all of the study activities and procedures
Participants or guardians are willing and able to give written informed consent for protocol PA18-0130 (Pediatric Energy balance data repository protocol), companion protocol for the Fitbit application/assessment

Exclusion

Patients whose clinical status precludes them from participating in any physical activity including but not limited to: declining respiratory status, hypoxia requiring high flow nasal cannula (Vapotherm), hypotension, and active bleeding.
At MD Anderson HSCT patients admitted to adult units for their transplant will not be eligible as TEAM Me is an established program on the G9 Pediatrics Unit only

What this trial measures

  • Proportion of patients who enroll and complete the serial measuresUp to 21 days post-hematopoietic stem cell transplant (HSCT)

    Will consider the program feasible if 75% of patients approached about the study will agree to enroll and 80% of the enrolled subjects will participate in physical activity and complete the serial measures for 70% of their inpatient days until day +21. Will report the percentage with 95% confidence interval of approached patients that agree to participate at the end of the study. Each patient's percentage of days that he/she complete the serial measures until day +21 will be calculated and percentage of all patients that finish 70% of the 21 day serial measures will be estimated with 95% confidence interval.

  • Incidence of adverse events.Up to 100 days post-HSCT

    The program will be considered tolerable if \> 90% of the participants do not have any Common Terminology Criteria for Adverse Events defined adverse events that are greater than grade 2. Serious adverse event will be defined using Common Terminology Criteria for Adverse Events version 5.0 or higher.